Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 10;44(9):876-881.
doi: 10.1097/INF.0000000000004831.

Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection

Affiliations

Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection

Sampson Antwi et al. Pediatr Infect Dis J. .

Abstract

Background: There is limited data on the cellular pharmacokinetics (PK) of the nucleos(t)ide reverse transcriptase inhibitors (NRTIs) in adolescents with HIV (AWH). We examined the steady-state concentrations of the NRTIs anabolites in dried blood spots (DBS) and peripheral blood mononuclear cells (PBMCs) in AWH and those with tuberculosis (TB) confection on rifampin-containing TB treatment.

Methods: AWH and TB/HIV coinfection on TB treatment receiving tenofovir (TFV) disoproxil fumarate (TDF) 300 mg/lamivudine (3TC) 300 mg or emtricitabine (FTC) 200 mg daily for at least 8 weeks were enrolled. DBS were collected at the study entry. Following 2 weeks of telephone adherence reminders, DBS sampling was repeated, and 4 PBMC samples were collected between 10 and 20 hours postdose. Concentrations of TFV diphosphate (TFV-DP), 3TC triphosphate and FTC triphosphate in DBS and PBMCs were measured. Adherence based on TFV-DP concentrations in DBS and the anabolites concentrations in DBS and PBMCs were compared by TB coinfection status, and ≤14 versus >14 years old.

Results: Of 52 participants (46.2% with TB), the median (interquartile range) age 15.0 (14.5-17.0) years, 25 (48.1%) were male. Adherence based on TFV-DP in DBS was not significantly different by TB coinfection status or age group. The concentrations of the anabolites in DBS and PBMCs were similar in AWH and TB/HIV coinfection and ≤14 versus >14 years of age; and median concentrations at the population level were similar to historical values in adults.

Conclusions: The concentrations of the recommended NRTIs and pharmacokinetics-determined adherence were not significantly different in adolescents with TB or younger age.

Keywords: adolescents; emtricitabine triphosphate; lamivudine triphosphate; pharmacokinetics; tenofovir diphosphate.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. Organization WH. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. Available at: https://www.who.int/publications/i/item/9789240031593. Accessed (August 7, 2021). 2021. - PubMed
    1. Anderson PL, Kakuda TN, Kawle S, Fletcher CV. Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals. AIDS. 2003;17(15):2159–68. - PubMed
    1. Fletcher CV, Kawle SP, Kakuda TN, et al. Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons. AIDS. 2000;14(14):2137–44. - PubMed
    1. Stretcher BN, Pesce AJ, Frame PT, Greenberg KA, Stein DS. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity. AIDS. 1994;8(6):763–9. - PubMed
    1. Anderson PL, Liu AY, Castillo-Mancilla JR, et al. Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy. Antimicrob Agents Chemother. 2018;62(1):1–13. - PMC - PubMed

MeSH terms

LinkOut - more resources